A detailed history of Clearstead Advisors, LLC transactions in Lemaitre Vascular Inc stock. As of the latest transaction made, Clearstead Advisors, LLC holds 78 shares of LMAT stock, worth $8,421. This represents 0.0% of its overall portfolio holdings.

Number of Shares
78
Previous 78 -0.0%
Holding current value
$8,421
Previous $6,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$62.62 - $83.59 $187 - $250
3 Added 4.0%
78 $6,000
Q1 2024

May 14, 2024

BUY
$54.0 - $71.06 $2,106 - $2,771
39 Added 108.33%
75 $4,000
Q4 2023

Feb 12, 2024

BUY
$45.37 - $58.41 $1,633 - $2,102
36 New
36 $2,000
Q2 2022

Aug 12, 2022

SELL
$39.05 - $47.85 $1,483 - $1,818
-38 Closed
0 $0
Q1 2022

May 04, 2022

BUY
$40.48 - $51.5 $1,538 - $1,957
38 New
38 $2,000

Others Institutions Holding LMAT

About LEMAITRE VASCULAR INC


  • Ticker LMAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 21,962,900
  • Market Cap $2.37B
  • Description
  • LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that tem...
More about LMAT
Track This Portfolio

Track Clearstead Advisors, LLC Portfolio

Follow Clearstead Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Advisors, LLC with notifications on news.